Igor Nikolov

832 total citations
37 papers, 621 citations indexed

About

Igor Nikolov is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Igor Nikolov has authored 37 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nephrology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Igor Nikolov's work include Parathyroid Disorders and Treatments (13 papers), Dialysis and Renal Disease Management (9 papers) and Vitamin D Research Studies (5 papers). Igor Nikolov is often cited by papers focused on Parathyroid Disorders and Treatments (13 papers), Dialysis and Renal Disease Management (9 papers) and Vitamin D Research Studies (5 papers). Igor Nikolov collaborates with scholars based in North Macedonia, France and Austria. Igor Nikolov's co-authors include Tilman B. Drüeke, Ziad A. Massy, Bernard Lacour, Nobuhiko Joki, Julien Maizel, Ognen Ivanovski, Thao Nguyen‐Khoa, Olivier Phan, Ralf Westenfeld and Nadya Mothu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Igor Nikolov

30 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Nikolov North Macedonia 15 420 171 119 111 98 37 621
Massimo Morosetti Italy 13 430 1.0× 119 0.7× 92 0.8× 94 0.8× 118 1.2× 57 702
Charlotte A. te Velde‐Keyzer Netherlands 15 295 0.7× 246 1.4× 121 1.0× 132 1.2× 124 1.3× 37 701
Naseem Amin United States 6 780 1.9× 232 1.4× 131 1.1× 189 1.7× 265 2.7× 10 1.0k
Wasana Stitchantrakul Thailand 16 464 1.1× 70 0.4× 112 0.9× 87 0.8× 289 2.9× 34 912
João Frazão Portugal 18 898 2.1× 250 1.5× 377 3.2× 127 1.1× 167 1.7× 66 1.1k
Julia Lepenies Germany 12 295 0.7× 54 0.3× 110 0.9× 124 1.1× 128 1.3× 16 754
Lorenzo Gasperoni Italy 12 137 0.3× 111 0.6× 69 0.6× 101 0.9× 59 0.6× 30 518
Karin Shimada Japan 11 301 0.7× 126 0.7× 54 0.5× 36 0.3× 96 1.0× 25 446
Graciela Delgado Austria 14 322 0.8× 49 0.3× 144 1.2× 190 1.7× 38 0.4× 28 731
Liat Ganon Israel 9 318 0.8× 74 0.4× 291 2.4× 102 0.9× 61 0.6× 14 513

Countries citing papers authored by Igor Nikolov

Since Specialization
Citations

This map shows the geographic impact of Igor Nikolov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Nikolov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Nikolov more than expected).

Fields of papers citing papers by Igor Nikolov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Nikolov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Nikolov. The network helps show where Igor Nikolov may publish in the future.

Co-authorship network of co-authors of Igor Nikolov

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Nikolov. A scholar is included among the top collaborators of Igor Nikolov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Nikolov. Igor Nikolov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tasić, Velibor, et al.. (2025). Nephrotic Syndrome Induced by Tiopronin in a Male Patient with Cystinuria. Balkan Journal of Medical Genetics. 28(1). 20250012–20250012.
2.
Nikolov, Igor, et al.. (2024). MIXED PULMONARY INFECTION IN A PATIENT WITHSUCCESSFULLY TREATED RECURRENCE OF FOCALSEGMENTAL GLOMERULOSCLEROSIS ON KIDNEYALLOGRAFT. Archives of the Balkan Medical Union. 59(3). 308–313.
3.
4.
Nikolov, Igor, et al.. (2019). Complications and Risks of Percutaneous Renal Biopsy. Open Access Macedonian Journal of Medical Sciences. 7(6). 992–995. 26 indexed citations
5.
Nikolov, Igor, et al.. (2015). Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients. Renal Failure. 37(7). 1180–1184. 2 indexed citations
7.
Nikolov, Igor, Nadica Matevska-Geshkovska, Dan L. Dumitraşcu, et al.. (2015). Genetic predictors of the response to the treatment of hepatitis C virus infection. SHILAP Revista de lepidopterología. 15(4). 55–59. 3 indexed citations
8.
Nikolov, Igor, Nobuhiko Joki, Antoine Galmiche, et al.. (2013). Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice. Atherosclerosis. 229(1). 42–51. 16 indexed citations
9.
Nikolov, Igor, Nobuhiko Joki, Thao Nguyen‐Khoa, et al.. (2011). Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice. Nephrology Dialysis Transplantation. 27(2). 505–513. 46 indexed citations
10.
Nikolov, Igor, Nobuhiko Joki, Thao Nguyen‐Khoa, et al.. (2010). Chronic kidney disease bone and mineral disorder (CKD–MBD) in apolipoprotein E-deficient mice with chronic renal failure. Bone. 47(1). 156–163. 32 indexed citations
11.
Nikolov, Igor, Nobuhiko Joki, Natacha Patey, et al.. (2010). Tissue Accumulation of Lanthanum as Compared to Aluminum in Rats with Chronic Renal Failure – Possible Harmful Effects after Long-Term Exposure. Nephron Experimental Nephrology. 115(4). e112–e121. 28 indexed citations
12.
Tanaka, Yuri, Nobuhiko Joki, Masaki Iwasaki, et al.. (2010). Increment of monthly mean predialysis heart rate reflects early cardiac overload in hemodialysis patients with normal cardiac function. Journal of Nephrology. 24(2). 185–191. 3 indexed citations
13.
Joki, Nobuhiko, Igor Nikolov, Axelle Caudrillier, et al.. (2009). Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice. Bone. 45. S30–S34. 16 indexed citations
14.
Nikolov, Igor, Anaïs Mozar, Tilman B. Drüeke, & Ziad A. Massy. (2009). Impact of Disturbances of Calcium and Phosphate Metabolism on Vascular Calcification and Clinical Outcomes in Patients with Chronic Kidney Disease. Blood Purification. 27(4). 350–359. 27 indexed citations
15.
Ivanovski, Ognen, Igor Nikolov, Nobuhiko Joki, et al.. (2008). The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE−/−) mice. Atherosclerosis. 205(1). 55–62. 93 indexed citations
16.
Sikole, Aleksandar, et al.. (2007). Treatment of Hepatitis C in Hemodialysis Patients with Pegylated Interferon α-2a as Monotherapy. Renal Failure. 29(8). 961–966. 20 indexed citations
17.
Phan, Olivier, Ognen Ivanovski, Igor Nikolov, et al.. (2007). Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure. Nephrology Dialysis Transplantation. 23(1). 82–90. 40 indexed citations
18.
Ivanovski, Ognen, et al.. (2007). Atherosclerosis and vascular calcification in uraemia - a new experimental model.. PubMed. 28(2). 11–24. 7 indexed citations
19.
Nikolov, Igor, Nobuhiko Joki, Julien Maizel, et al.. (2006). Pleiotropic effects of the non-calcium phosphate binder sevelamer. Kidney International. 70(105). S16–S23. 36 indexed citations
20.
Phan, Olivier, Ognen Ivanovski, Nadya Mothu, et al.. (2005). Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E deficient (apoE -/- ) mice Short title: Sevelamer prevents atherosclerosis in uremic mice. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026